Ginkgo director may sell 5,000 shares, $35K value

Ginkgo Bioworks Holdings, Inc. (DNA) received a notice under Rule 144 that director Henry Christian O, through Fidelity Brokerage Services LLC, may sell 5,000 Class A shares.

Rhea-AI Filing Summary

Ginkgo Bioworks Holdings, Inc. (DNA) received a notice under Rule 144 that director Henry Christian O, through Fidelity Brokerage Services LLC, may sell 5,000 Class A shares. The planned sale has an aggregate market value of $35,405.99, with 55,383,808 Class A shares outstanding as of September 15, 2026.

Key Figures

Shares to be sold: 5,000 shares Aggregate market value: $35,405.99 Shares outstanding: 55,383,808 shares +1 more

4 metrics

Shares to be sold 5,000 shares Class A shares covered by the Rule 144 notice

Aggregate market value $35,405.99 Market value of the 5,000 Class A shares subject to the planned sale

Shares outstanding 55,383,808 shares Class A shares outstanding as of September 15, 2026

Planned sale date September 15, 2026 Date associated with the potential Rule 144 sale on the NYSE

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Class A | 03/11/2022 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Christian Henry."

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for Ginkgo Bioworks (DNA)?

The filing reports that director Henry Christian O may sell 5,000 Class A shares of Ginkgo Bioworks Holdings, Inc. under Rule 144. It is a notice of a potential sale, not confirmation that the shares have been sold.

How many Ginkgo Bioworks (DNA) shares are covered by this Form 144?

The notice covers a potential sale of 5,000 Class A shares of Ginkgo Bioworks Holdings, Inc. These shares are to be sold through Fidelity Brokerage Services LLC on the NYSE.

What is the value of the Ginkgo Bioworks (DNA) shares in this planned Rule 144 sale?

The planned sale has an aggregate market value of $35,405.99 for the 5,000 Class A shares referenced in the Rule 144 notice.

How many Ginkgo Bioworks (DNA) shares were outstanding at the time of this Form 144?

The notice reports 55,383,808 Class A shares outstanding as of September 15, 2026. This figure provides context for the size of the potential 5,000-share sale.

Who is selling the Ginkgo Bioworks (DNA) shares and who signed the Form 144?

The securities are for the account of director Henry Christian O. The notice is signed by Jessica Spraker, as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Christian Henry.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 11:48 AM Accepted by SEC EDGAR 09/15/2026 - 11:47 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001263805
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Ginkgo Bioworks Holdings, Inc.
SEC File Number	001-40097
Address of Issuer	27 DRYDOCK AVENUE 8TH FLOOR BOSTON MASSACHUSETTS 02210
Phone	(877) 442-5362
Name of Person for Whose Account the Securities are To Be Sold	HENRY CHRISTIAN O
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5000	35405.99	55383808	09/15/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	03/11/2022	Restricted Stock Vesting	Issuer			3425	03/11/2022	Compensation
Class A	04/01/2022	Restricted Stock Vesting	Issuer			6	04/01/2022	Compensation
Class A	05/01/2022	Restricted Stock Vesting	Issuer			6	05/01/2022	Compensation
Class A	06/01/2022	Restricted Stock Vesting	Issuer			6	06/01/2022	Compensation
Class A	07/01/2022	Restricted Stock Vesting	Issuer			6	07/01/2022	Compensation
Class A	08/01/2022	Restricted Stock Vesting	Issuer			6	08/01/2022	Compensation
Class A	09/01/2022	Restricted Stock Vesting	Issuer			6	09/01/2022	Compensation
Class A	11/01/2022	Restricted Stock Vesting	Issuer			1025	11/01/2022	Compensation
Class A	12/01/2022	Restricted Stock Vesting	Issuer			98	12/01/2022	Compensation
Class A	01/03/2023	Restricted Stock Vesting	Issuer			98	01/03/2023	Compensation
Class A	02/01/2023	Restricted Stock Vesting	Issuer			98	02/01/2023	Compensation
Class A	03/01/2023	Restricted Stock Vesting	Issuer			98	03/01/2023	Compensation
Class A	04/01/2023	Restricted Stock Vesting	Issuer			98	04/01/2023	Compensation
Class A	05/01/2023	Restricted Stock Vesting	Issuer			24	05/01/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jessica Spraker, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Christian Henry.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)